A biopharmaceutical company focused on discovering, developing and commercializing small molecule drugs that address severe medical conditions with potential markets, including cancer and chronic inflammatory diseases.
The best Bull and Bear pitches based on recency and number of recommendations.
Surge of insider buying inspires confidence. While this means nothing if the drug ultimately doesn't fly, or heavy dilution tramples existing shareholders, the company has a good balance sheet due to the recent capital raise.
There's always that one last moment of hesitation before I hit the underperform button on an oncology stock in CAPS. Last chance to avoid making a fool of myself focusing on the corpse of a failed lead drug and completely unaware of the hot new… More
Read the most recent pitches from players about SNTA.DL.
Find the members with the highest scoring picks in SNTA.DL.
See what the Wall Street professionals think, according to their public statements and filings.